Cantor Fitzgerald Weighs in on MLTX FY2026 Earnings
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of MoonLake Immunotherapeutics in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal forecasts that the company will post earnings per share of ($3.78) for the year. The […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of MoonLake Immunotherapeutics in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal forecasts that the company will post earnings per share of ($3.78) for the year. The […]
